Previous studies from our group and others aimed at blocking OPN cleavage in vivo by pharmacologically inhibiting thrombin indicate that inhibition of thrombin can reduce malignant and metastatic behavior of breast cancer cells using both OPN-dependent and OPN-independent mechanisms [24,50]. Here, SPP1 is linked to breast cancer.